By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

ACCOUNTABILITIES

• Plan, author, review, update and manage nonclinical components of regulatory documents such as Briefing Books (BB), Investigator’s Brochures (IBs), Investigational New Drug Applications (INDs), Clinical Trial Applications (CTAs), Investigator’s Brochures (IBs), New Drug Applications (NDAs), Biologic License Applications (BLAs), Marketing Authorization Applications (MAAs), responses to queries (RTQs), and various annual reports (DSUR, DSUR, PBRER) for drug products across Takeda’s R&D portfolio (preclinical through marketed) and Takeda’s major therapeutic areas (Oncology, Gastrointestinal & Inflammation, Neuroscience, Rare Disease) with a focus on First in Human (FIH) programs .
• Apply advanced knowledge and experience to assess document requirements, develop writing strategy, compose drafts, identify information gaps or other potential issues, and facilitate document finalization for regulatory-compliant submissions, while ensuring alignment with International Conference on Harmonization (ICH) guidelines, regulatory requirements, and Takeda’s policies and processes.
• Understand and apply the principles of regulatory writing and lean authoring, writing with the audience in mind and conveying messages in a clear and concise manner when presenting pharmacology, pharmacokinetics and toxicology data and strategies.
• Lead nonclinical submission working groups to liaise effectively with cross-functional team members (Program Management, Global Regulatory Affairs, Regulatory Operations, Drug Discovery Units, DMPK&M, and Drug Safety Research and Evaluation) to recognize aims, align on strategy, define executable timelines, and agree upon content for nonclinical regulatory submissions.
• Represent NRWS on cross-functional teams (Clinical, Global Patient Safety, Program Management, Global Regulatory Affairs, Regulatory Operations) to plan, generate, manage, finalize and communicate about nonclinical documents for regulatory submissions. Generate nonclinical timelines. Liaise effectively with cross-functional team members to communicate aims, content requirements, and timelines.
• Implement and drive continuous improvement by integrating automation, innovative practices and new technologies including AI/GenAI and RPA into the technical and regulatory writing framework, streamlining document life cycle management processes and fostering an environment of forward-thinking excellence.
• Develop practical timelines (Microsoft Project) for deliverables

EDUCATION, BEHAVIOURAL COMPETENCIES AND SKILLS:

• Ph.D. or M.Sc. in scientific field (e.g., biology, pharmacology, toxicology), with minimum of 8 years of experience with nonclinical regulatory writing within the pharmaceutical industry or Contract Research Organization (CRO).
• Significant experience in direct authoring of nonclinical summary sections to support regulatory submissions, including but not limited to IBs, briefing books, INDs (including FIH), periodic reports, NDAs/MAAs/BLAs, and agency responses to queries.
• Experience in drug product development across numerous modalities (small molecule, biologics, cell therapies, etc.), with direct involvement in regulated studies related to pharmacology, toxicology, or pharmacokinetics demonstrating a broad understanding of the drug development process (from preclinical through post-marketing stages).
• Experience in program management, with ability to prioritize, manage multiple programs within strict regulatory/compliance deadlines, and lead internal/external and scientific teams to regulatory submission aims.
• Thorough understanding of regulatory guidelines related to global submissions and submission content (e.g., FDA/EMA/PMDA regulations; ICH guidance; GLP/GCP requirements; SEND requirements, etc.) and ability to interpret and apply these guidelines. Regulatory Affairs Credential (RAC-Drugs) is an advantage.
• Forward thinking and passionate about driving innovation and continuous improvement who excels at identifying, testing, and implementing new technologies to enhance our writing framework.
• Demonstrate Digital Dexterity.
• Details oriented with strong verbal, written, and interpersonal communication skills, active listening, and influencing skills; establishes and maintains professional and productive working relationships with internal and external stakeholders.
• Possession of innovative problem-solving skills and develop ability to impact outcomes through influence, not direct authority.
• Ability to operate in a fast-paced environment and manage multiple activities, priorities, and deadlines and willingness to broaden knowledge in complementary fields
• Ability to rapidly adjust to new, unknown, and/or challenging situations is mandatory.
• Demonstrated ability to work in a global ecosystem (internal and external) with a high degree of complexity.

TAKEDA COMPENSATION AND BENEFITS SUMMARY

We understand compensation is an important factor as you consider the next step in your career. We are committed to equitable pay for all employees, and we strive to be more transparent with our pay practices.

• Develop, manage, and execute nonclinical regulatory writing in a variety of projects of diverse scope and complexity across multiple therapeutic areas, geographic regions and development phases.
• Champion continuous improvement by integrating automation and innovative practices into the technical and regulatory writing framework, streamlining processes and fostering an environment of forward-thinking excellence.
• Serve as the NRWS representative on cross-functional initiatives, when required.